These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3107814)

  • 1. From pathogenesis to hormone prevention of mammary carcinogenesis.
    Russo IH; Russo J
    Cancer Surv; 1986; 5(3):649-70. PubMed ID: 3107814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a physiological approach to breast cancer prevention.
    Russo J; Russo IH
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):353-64. PubMed ID: 8061586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis of cellular autonomy in the susceptibility to carcinogenesis.
    Russo J
    Toxicol Pathol; 1983; 11(2):149-66. PubMed ID: 6443045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis.
    Russo J; Tay LK; Ciocca DR; Russo IH
    Environ Health Perspect; 1983 Mar; 49():185-99. PubMed ID: 6403347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat.
    Ip C; Singh M; Thompson HJ; Scimeca JA
    Cancer Res; 1994 Mar; 54(5):1212-5. PubMed ID: 8118808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.
    Russo J; Wilgus G; Russo IH
    Am J Pathol; 1979 Sep; 96(3):721-36. PubMed ID: 112872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestagens and mammary gland development: differentiation versus carcinogenesis.
    Russo IH; Russo J
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():7-12. PubMed ID: 1839345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence.
    Russo J; Russo IH
    Am J Pathol; 1980 Aug; 100(2):497-512. PubMed ID: 6773421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol.
    Russo IH; Frederick J; Russo J
    Breast Cancer Res Treat; 1989 Oct; 14(1):43-56. PubMed ID: 2513893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone prevention of mammary carcinogenesis: a new approach in anticancer research.
    Russo IH; Russo J
    Anticancer Res; 1988; 8(6):1247-64. PubMed ID: 3146243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis.
    Russo J; Russo IH
    Cancer Res; 1980 Aug; 40(8 Pt 1):2677-87. PubMed ID: 7388818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk.
    Thompson H; Zhu Z; Banni S; Darcy K; Loftus T; Ip C
    Cancer Res; 1997 Nov; 57(22):5067-72. PubMed ID: 9371504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis.
    Russo IH; Koszalka M; Russo J
    Carcinogenesis; 1990 Oct; 11(10):1849-55. PubMed ID: 2119909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY; Kimler BF; Fabian CJ; Petroff BK
    Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation and breast cancer.
    Russo J; Russo IH
    Medicina (B Aires); 1997; 57 Suppl 2():81-91. PubMed ID: 9567346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma.
    Russo J; Tait L; Russo IH
    Am J Pathol; 1983 Oct; 113(1):50-66. PubMed ID: 6312803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated administration of carcinogen in critical developmental periods increases susceptibility of female Wistar: han rats to mammary carcinogenesis induction.
    Bojková B; Ahlers I; Kubatka P; Mociková K; Mníchová M; Ahlersová E
    Neoplasma; 2000; 47(4):230-3. PubMed ID: 11043827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
    Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH
    Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis by concomitant or postcarcinogen antioxidant exposure.
    McCormick DL; Major N; Moon RC
    Cancer Res; 1984 Jul; 44(7):2858-63. PubMed ID: 6426789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of varying photoperiods on mammary morphology, DNA synthesis, and hormone profile in female rats.
    Mhatre MC; Shah PN; Juneja HS
    J Natl Cancer Inst; 1984 Jun; 72(6):1411-6. PubMed ID: 6427503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.